Ching-Hsin Chang

627 total citations
27 papers, 469 citations indexed

About

Ching-Hsin Chang is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Ching-Hsin Chang has authored 27 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Molecular Biology. Recurrent topics in Ching-Hsin Chang's work include Prostate Cancer Treatment and Research (9 papers), Hormonal and reproductive studies (6 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). Ching-Hsin Chang is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Hormonal and reproductive studies (6 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). Ching-Hsin Chang collaborates with scholars based in United States, Taiwan and Czechia. Ching-Hsin Chang's co-authors include David R. Rowley, Donald J. Tindall, Thomas J. Lobl, Tzu‐Ping Lin, Eric L. Rickes, Gerard J. Hickey, R G Smith, Liam P. McGuire, D. J. Tindall and Jennifer E. Drisko and has published in prestigious journals such as Biochemistry, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Ching-Hsin Chang

24 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching-Hsin Chang United States 12 233 117 110 103 65 27 469
H Yano Japan 12 68 0.3× 217 1.9× 23 0.2× 43 0.4× 24 0.4× 36 523
Xiaolu Jiao China 11 54 0.2× 114 1.0× 65 0.6× 87 0.8× 45 0.7× 39 394
Kerstin Dietrich Germany 13 70 0.3× 160 1.4× 30 0.3× 15 0.1× 28 0.4× 14 438
Thomas Sparre Denmark 16 214 0.9× 178 1.5× 40 0.4× 15 0.1× 10 0.2× 46 661
Go Tajima Japan 15 29 0.1× 285 2.4× 15 0.1× 60 0.6× 10 0.2× 56 663
L Leclerc France 13 79 0.3× 192 1.6× 18 0.2× 25 0.2× 17 0.3× 37 457
Bas W.D. de Jong Netherlands 10 19 0.1× 76 0.6× 9 0.1× 54 0.5× 17 0.3× 17 412
Rania Abu‐Hamdah United States 11 199 0.9× 289 2.5× 27 0.2× 28 0.3× 6 0.1× 12 545

Countries citing papers authored by Ching-Hsin Chang

Since Specialization
Citations

This map shows the geographic impact of Ching-Hsin Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-Hsin Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-Hsin Chang more than expected).

Fields of papers citing papers by Ching-Hsin Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching-Hsin Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-Hsin Chang. The network helps show where Ching-Hsin Chang may publish in the future.

Co-authorship network of co-authors of Ching-Hsin Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Ching-Hsin Chang. A scholar is included among the top collaborators of Ching-Hsin Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching-Hsin Chang. Ching-Hsin Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shih, Jing-Wen, Ching-Hsin Chang, Bashir Lawal, et al.. (2025). Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub. International Journal of Medical Sciences. 22(5). 1194–1207.
2.
Chang, Ching-Hsin, et al.. (2024). Prostate health index density aids the diagnosis of prostate cancer detected using magnetic resonance imaging targeted prostate biopsy in Taiwanese multicenter study. Journal of the Chinese Medical Association. 87(7). 678–685. 3 indexed citations
3.
Chang, Ching-Hsin, Mel Campbell, Chin‐Chen Pan, et al.. (2023). REST-repressed lncRNA LINC01801 induces neuroendocrine differentiation in prostate cancer via transcriptional activation of autophagy.. PubMed. 13(9). 3983–4002. 5 indexed citations
4.
Chang, Ching-Hsin, et al.. (2021). Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative Interventions. Aging and Disease. 12(3). 868–868. 11 indexed citations
5.
Chang, Ching-Hsin, et al.. (2019). Safety and effectiveness of high-power thulium laser enucleation of the prostate in patients with glands larger than 80 mL. BMC Urology. 19(1). 8–8. 18 indexed citations
6.
7.
Lin, Tzu‐Ping, Mel Campbell, Ching-Hsin Chang, et al.. (2018). HOTAIR is a REST-regulated lncRNA that promotes neuroendocrine differentiation in castration resistant prostate cancer. Cancer Letters. 433. 43–52. 56 indexed citations
8.
Hsu, Che-Hao, et al.. (2018). Cardiac Arrest in Patient Who Underwent Transoral Endoscopic Thyroidectomy : Case Report. 12(2). 113–117. 1 indexed citations
9.
Chang, Ching-Hsin, et al.. (2015). Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study. BMC Urology. 15(1). 40–40. 21 indexed citations
10.
11.
12.
Chang, Ching-Hsin, et al.. (2011). Bladder outlet obstruction due to labial agglutination. Journal of the Chinese Medical Association. 75(1). 40–42. 7 indexed citations
13.
Cunningham, Patrick N., Eric L. Rickes, Lesley A. McNamara, et al.. (1999). Administration of a Nonpeptidyl Growth Hormone Secretagogue, L‐163,255, Changes Somatostatin Pattern, But Has No Effect on Patterns of Growth Hormone‐Releasing Factor in the Hypophyseal‐Portal Circulation of the Conscious Pig. Proceedings of The Society for Experimental Biology and Medicine. 222(1). 70–77. 11 indexed citations
14.
Drisko, Jennifer E., Ching-Hsin Chang, D. F. Hora, et al.. (1998). Hypophyseal-Portal Concentrations of Growth Hormone-Releasing Factor and Somatostatin in Conscious Pigs: Relationship to Production of Spontaneous Growth Hormone Pulses. Experimental Biology and Medicine. 217(2). 188–196. 30 indexed citations
15.
Hickey, Gerard J., Jennifer E. Drisko, Ching-Hsin Chang, et al.. (1996). Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585. Journal of Endocrinology. 148(2). 371–380. 87 indexed citations
16.
Chang, Ching-Hsin, Eric L. Rickes, Liam P. McGuire, et al.. (1996). Growth hormone (GH) and insulin-like growth factor I responses after treatments with an orally active GH secretagogue L-163,255 in swine.. Endocrinology. 137(11). 4851–4856. 15 indexed citations
17.
Hickey, Gerard J., et al.. (1993). Effects of Prednisone on Dermal Responses in Flea‐Allergen Hypersensitized Dogs. Veterinary Dermatology. 4(2). 71–77. 1 indexed citations
18.
Zuo, Li, et al.. (1992). A new mutation responsible for severe G6PD deficiency in two ethnic Chinese with different clinical presentations: determination by a direct PCR sequencing technique.. PubMed. 55(1). 39–44. 4 indexed citations
19.
Chang, Ching-Hsin, et al.. (1985). Physicochemical Characterization of the Androgen Receptor From Hyperplastic Human Prostate. The Journal of Urology. 133(5). 926–927. 1 indexed citations
20.
Tindall, D. J., Ching-Hsin Chang, Thomas J. Lobl, & Glenn R. Cunningham. (1984). Androgen antagonists in androgen target tissues. Pharmacology & Therapeutics. 24(3). 367–400. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Yano Breakdown of academic impact, for papers by Xiaolu Jiao Breakdown of academic impact, for papers by Kerstin Dietrich Breakdown of academic impact, for papers by Thomas Sparre Breakdown of academic impact, for papers by Go Tajima Breakdown of academic impact, for papers by L Leclerc Breakdown of academic impact, for papers by Bas W.D. de Jong Breakdown of academic impact, for papers by Rania Abu‐Hamdah
Rankless by CCL
2026